59-year-old female with history of hypothyroidism, insomnia, anxiety presenting for medication review and refills. Patient takes 25 mg of trazodone for sleep nightly, hopes to wean off this. Feels her mood overall is stat on current medication regimen. Of note, patient had a hospitalization in April 2024 for bilateral frontoparietal craniotomies for chronic subdu hematomas. This was found on MRI of brain following a head trauma 2 months prior. Patient had been havin: extreme headaches and dizziness, During this time patient was also placed on Keppra for seizure prophylaxis : well as amlodipine for high blood pressure, she is off both of these now. Patient has residual hand weakness a! continyes to work with occupational therapy. She is back to regular exercise however still cannot hold weights hold a tennis racquet due to her weakness. Dr Alexander Nonroloacical Associates. {20/2024 Lauren Bran eason for Appointment L. ds Pt transfer Med refills listory of Present illness Depression Screening: PHO-9 Little interest or pleasure in doing things Not at all Feeling down, depressed, or hopeless Not at all Trouble falling or staying asleep, or sleeping too much Not at all Feeling tired or having little energy Not at all Poor appetite or overeating Not at all Feeling bad about yourself or that you are a failure, or have let yourself or your family down Not at all Trouble concentrating on things, such as reading the newspaper or watching television Not at all Moving or speaking so slowly that other people could have noticed; or the opposite, being so fidgety or restle that you have been moving around a lot more than usual Not at all Thoughts that you would be better off dead or of hurting yourself in some way Not at ail Total Score o History: 59-year-old female with history of hypothyroidism, insomnia, anxiety presenting for medication review and refills. Patient takes 25 mg of trazodone for sleep nightly, hopes to wean off this. Feels her mood overall is stab on current medication regimen. Of note, patient had a hospitalization in April 2024 for bilateral frontoparietal craniotomies for chronic subdu! hematomas. This was found on MRI of brain following a head trauma 2 months prior, Patient had been having extreme headaches and dizziness, During this time patient was also placed on Keppra for seizure prophylaxis 2 well as amlodipine for high blood pressure, she is off both of these now. Patient has residual hand weakness ar continves to work with occupational therapy. She is back to regular exercise however still cannot hold weights hold a tennis racquet due to her weakness. Dr, Alexander Neurological Associates. surrent Medications Taking » Flonase 50 MCG/ACT Suspension 2 sprays in each nostril Nasally Once a day © 8 * Mucinex 600 MG Tablet Extended Release 12 Hour 1 tablet ag needed Orally every i2 hrs Mair Skin Nails ~ Capsule as directed Orally traZODone HCl s0 MG Tablet 1 tablet at bedtime as needed Orally Once a day , Notes to Pharmacist: 1/2 tab DULoxetine HC] 60 MG Capsule Delayed Release Particles take one capsule by mouth one time daily Orally Once a day , Notes to Pharmacist: LAST FILL KEEP UPCOMING APPT Synthroid 112 MOG Tablet 1 tablet Orally Once a day, Notes to Pharmacist: BRAND ONLY! viACYelovir HO) coo MC Tablot TARE ONE TABLET BY MOUTH ONE TIME DAILY Oral alization in April 2024 for bilateral frontoparietal craniotomies for chronic subc on MRI of brain following a head trauma 2 months prior. Patient had been havi ness, During this time patient was also placed on Keppra for seizure prophylaxi lood pressure, she is off both of these now. Patient has residual hand weakness yvational therapy. She is back to regular exercise however still cannot hold weigh Pwd, bb V% omy (Ref Range: 35-0-47.0 %) 233 (Ref Range: 430-400 K/ul) 12.8 (Ref OD (Ref Range: 35.0-47.0 %) 233 (Ref Range: 130-400 K/uL) 42,7 (Ref saben (Ref Range: 35.0-47.0 %) 229 (Ref Range: 130-400 K/uL) 12.7 (Ref ord (Ref Range: 35-0-47.0 %) 219 (Ref Range: 130-400 K/uL) 12,5 (Ref watery (Ref Range: 35.0-47.0 %) 240 (Ref Range: 130-400 K/ul) 13.8 (Ref Nee LAN LANen qantas LAWS Range: Range: Range: Range: Range: 26.0-34.0 26.0-34.0 26.0-34.0 26.0-34.0 26,0-34.0 pg) Pg) Ps) pg) pg) C 32.6 34.0 33.0 33-5 33.4 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 31,0°35,0 31.0°35.0 31.0-35.0 31,0-3§.0 31.0-35.0 g/dL} g/dL) g/dl) g/dl) g/dL) hocyte 30.2 315 39.5 38.4 29.0 (Ref (Ref (Ref (Ref . (Ref Ranga Ranon Ronan Ranga: Randa: 233 233 229 219 240 at | (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 130-400 130-400 180-400 130-400 130-400 K/ul) K/uL) K/ubL) K/ul) K/ul) AV% = 12.8 12.7 12.7 12.5 13.8 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: W5714.5 11.5°14.5 .5-146.5 11.5-14.5 11.5+14.5 %) %) %) %) %) 91.6 91.7 93.0 94.4 93.4 (Ref (Ref (Ref (Ref (Ref Range; Range: Range: Range: Range: 80.0-99.0 80,0-99.0 80,0+99.0 80.0°99.0 80.0-99.0 fL) fL) fL) fL) fL} 29.8 312 30.7 31.6 311 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 26.0-34.0 26.0-34.0 26.0-34.0 26.0-34.0 26,0-34.0 pg) Pg) Ps) pg) pg) - 32.6 34.0 33.0 33-5 33.4 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 31.0°35,0 31.0°35.0 31.0-35.0 31,0-35.0 31.0-35.0 g/dL} g/dL) g/dl) g/dl) g/dL) hocyte 30.2 315 39.5 38.4 29.0 (Ref (Ref (Ref (Ref . (Ref Range: Range: Range: Range: Range: VW74°5L7 174-517 1749517 17.4°51,7 17.4°51.7 %) %) %) ‘- a ~_ %) %) noglobin 12.5 12.4 12.7 1.9 13.0 (Ref (Ref (Ref {Ref (Ref Range: Range: Range: Range: Range: 11.§-16.0 12.5°16.0 11.9-16.0 11.§-16.0 11.5~16.0 g/dL) g/dl) g/dl) g/dl) g/dL) natocrit 38.4 36.5 38.5 35.5 38.9 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: $5-0-47.0 35.0-47.0 35.0°47.0 35.0-47.0 35.0-47.0 %) %) %) %) %) elet 233 233 229 219 240 nt (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 130-400 130-400 180-400 130-400 130-400 K/ul) K/uL) K/ubL) K/ul) K/ul) V-CV% 12.8 12.7 12.7 12.5 13.8 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: W545 1154.5 U5-14.5 5-145 11.5+14.5 %) %) %) %) %) V 91.6 91.7 93.0 94.4 93.1 (Ref (Ref (Ref (Ref (Ref Ranga: Ranee: Range: Rane: Range: 04/03/24 1553 AP.GILRI Order ENTER in POM 04/03/24 1553 AP.GILRI Ordering Doctor: Gilliam,Richard R NP 04/03/24 1623 3BAZ0038 order acknowledged 04/04/24 0001 interface cc'd doctors edited in LAB 04/04/24 0001 interface order’s status changed from TRANS to LOGGED by LAB 04/04/24 0611 interface order’s status changed from LOGGED to IN PRO by LAB 04/04/24 0616 interface order's status changed from IN PRO to COMP by LAB WO CON D OB Co PO Fe 04/03/24 1553 AP.GILRI 04/03/24 1553 AP.GILRI 04/03/24 1623 3BAZ0038 04/04/24 0001 interface 04/04/24 0001 interface 04/04/24 0611 interface 04/04/24 0634 interface Order ENTER in POM Ordering Doctor: Gilliam,Richard R NP order acknowledged ce’d doctors edited in LAB order’s status changed from TRANS to LOGGED by LAB order’s status changed from LOGGED to IN PRO by LAB order’s status changed from IN PRO to COMP by LAB 04/04/24 0925 DR.WILDA4 Order ENTER in POM 04/04/24 0925 DR.WILDA4 Order from set: PACU Adult 04/04/24 0925 DR.WILDA4 Ordering Doctor: Williams.David G.A. MD 04/04/24 0925 DR.WILDA4 Order Source: EPOM RONMrH cha order acknowledged Order marked to be continued 04/04/24 1313 3NNI9254 04/06/24 1652 DR.KOHJAL 10 04/06/24 2055 PWSNS10 Order RECEIVE in NUR 11 04/06/24 2055 PWSNS10 Ordering Doctor: Kohout, Jaromir MD 12 04/06/24 2055 PWSNS10 Order Source: EPOM 13 04/06/24 2055 PWSNS10 Order continued upon patient transfer. 14 = 04/06/24 2058 PWSNS10 order acknowledged 04/04/24 0925 DR.WILDA4 Order ENTER in POM 04/04/24 0925 DR.WILDA4 Order from set: PACU Adult 04/04/24 0925 DR.WILDA4 Ordering Doctor: Williams David G.A. MD 04/04/24 0925 interface ord S 04/04/24 1313 3NNI9254 order acknowledged 04/06/24 1652 DR.KOHJAl Order marked to be continued upon patient transfer er in NU 04/06/24 2055 PWSNS10 Ordering Doctor: Kohout Jaromir MD 04/06/24 2055 PWSNS10 Order Source: EPOM 04/06/24 2055 PWSNS10 Order continued upon patient transfer.